Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
IIVS and Toxys agree to offer ToxTracker for in vitro genetic toxicity evaluation
, /in E-News /by panglobalThe Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker assay. ToxTracker is an innovative in vitro assay allowing identification of the genotoxic and potentially carcinogenic properties of novel and existing drugs, (agro)chemicals, cosmetics and other substances without the use of animal testing.
Siemens Healthineers and Sysmex agree to supply haemostasis instruments, reagents as OEMs
, /in E-News /by panglobalSiemens Healthineers has signed a global OEM agreement on haemostasis products with Sysmex Corporation under which each company will supply the other with their products in the diagnostic field of haemostasis on an OEM basis.
ProBioGen makes three new appointments to support growth
, /in E-News /by panglobalProBioGen has seen significant growth with over 300 employees now working across its three locations in Berlin. In line with this growth, three crucial positions have been filled. Julian Collins has been appointed as Senior Vice President, Head of People & Organizational Development (P&OD) and a member of the Executive Team, while Dr Michiel Stork […]
Insight into clinical sample and consent tracking
, /in Featured Articles /by panglobalClinical specimens, clinical trial samples and the information associated with them are precious resources that require careful curation. CLI caught up with David Kaye [Vice President and General Manager of BioFortis (a Q2 Solutions company)] to find out more about what this entails.
Detection of intrathecal antibody synthesis in CNS diseases
, /in Featured Articles /by panglobalThe investigation of antibodies against pathogenic agents in cerebrospinal fluid (CSF) samples is part of the diagnostic work up in acute or chronic inflammatory processes of the central nervous system. This article describes the analysis of intrathecally produced antibodies in CSF and the interpretation of the results.
How should microbiology laboratories be prepared for the next unknown?
, /in Featured Articles, Microbiology /by panglobalWhat we learned from the last pandemic, which no one saw coming, is that it is difficult to answer the question “How should microbiology laboratories be prepared for the next unknown?” However, the last pandemic also taught us that it is imperative to try to answer such a question. In this article we will try […]
Minimizing the number of false positives in dexamethasone suppression testing for the diagnosis of Cushing’s syndrome
, /in Featured Articles /by panglobalCushing’s syndrome is related to high production of cortisol and, without timely treatment, it can lead to complications such as heart attacks, strokes and type 2 diabetes. The condition can be diagnosed using a dexamethasone suppression test, which involves tracking the effects of this glucocorticoid medication on cortisol levels. Since the absorption of dexamethasone depends […]
Next-generation apo(a) standardization: why, when and how?
, /in Featured Articles /by panglobalThere is a revival of the genetically determined cardiovascular risk factor Lp(a). Yet, it is one of the most complicated clinical chemistry parameters, and up to 2-fold variation in measurement results may be observed between in vitro diagnostic tests. A next-generation reference measurement system based on mass spectrometry – and endorsed by the International Federation […]
Vitestro raises EUR 12 million in Series A financing round to bring the world’s first autonomous blood drawing device to the European market
, /in E-News /by panglobalVitestro, developer of an autonomous blood drawing device, announces the completion of a EUR 12 million Series A financing round. California-based Sonder Capital led the funding round alongside existing investors and new private investors with experience in the clinical laboratory and MedTech industry.
Bio-Rad Launches PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers
, /in E-News /by panglobalEnhanced usability to support PCR applications in basic and translational research, process development, and quality control